Radiation applied to health Archives

Bertrand Desmets In BioWin news, Radiation applied to health

Science for Health 2024: from innovation to implementation of AI and digitalisation in healthcare

Brussels, Belgium, 4 November 2024 - The Science for Health 2024 event co-organised by BioWin and MEDVIA is taking place on 12 November in Brussels. Healthcare innovators, technology leaders, and policy influencers will be brought together to explore the theme of AI, data, and digitalisation in healthcare. With a forward-looking...

Bertrand Desmets In BioWin news, Radiation applied to health

Call 43 for collaborative R&I projects

Call 43 for collaborative R&I projects Do you have an innovative project idea and are you looking for partners to make it concrete? Your project is part of one of the strategic themes supported by the cluster, i.e: biopharmacy and biotechnology, medtech, eHealth. These themes are in line with the Stratégie de la Spécialisation Intelligente...

Bertrand Desmets In Radiation applied to health

NucleoGlio

Glioblastomas are highly aggressive forms of brain cancer, posing a significant clinical challenge, especially in cases of recurrence following surgical resection. In this regard, a team of researchers has focused on the non-invasive liquid biopsy approach for both the initial diagnosis or recurrence of glioblastoma, as well as for the...

Bertrand Desmets In Radiation applied to health

Website survey

Dear Visitors and Members, Welcome to our website! We are dedicated to improving your user experience continuously. Your feedback matters, and we have designed this survey to help us achieve that. Please share your thoughts to make our platform better. Thank you for your participation, The Biowin team

Alexandra Schiettekatte In Radiation applied to health

Save the Date HealthTech Innovation Days 2023

Save the date 5ème édition des HealthTech Innovation Days 24 & 25 OCTOBRE 2023 À Paris 27 octobre 2023 uniquement en virtuel Événement phare de l'écosystème européen de l'innovation en santé, organisé grâce à des mécènes engagés dans ce secteur, pour favoriser l’accès aux nouvelles technologies pour tous les...

Bertrand Desmets In Radiation applied to health

Immunochem

Immunochem is a small company active in the IVD sector, specialised in the generation of high quality antibodies. Building on this expertise, Immunochem holds a promising idea by setting up new research and development projects tackling the AMR problematic. The principal focus at Immunochem is antibody development and sales, especially...

Bertrand Desmets In M, Radiation applied to health, Service provider

Marsh BeLux

Our purpose is Possibility. At Marsh, the idea of possibility isn’t just something we talk about — it’s something we've lived for over 150 years. We help our clients and colleagues grow — and our communities thrive — by protecting and promoting Possibility. We seek better ways to manage risk...

Alexandra Schiettekatte In Radiation applied to health

EANM – European Association of Nuclear Medicine 2022

Exhibition - EANM 2022 Congress Annual Congress of the European Association of Nuclear Medicine October 15 - 19, 2022, Barcelona, SPAIN AWEX Collective Pavilion _____________________________ The Walloon Export and Foreign Investment Agency (AWEX) will organize a collective participation in the 35th Annual Congress of the European Association of Nuclear Medicine...

Alexandra Schiettekatte In Medical Devices and In Vitro Diagnostics, Radiation applied to health, Regional

D-CAF

The objective of the D-CAF project is to develop a measurement toolkit in order to meet the next dosimetric challenges linked to the marketing of new particle therapy systems and to advances in radiotherapeutic techniques. In this context, the main ambition of the D-CAF project is to push innovation in...

Elisa Wolf In Radiation applied to health

Ziphius Vaccines NV

Ziphius Vaccines is a global biopharmaceutical company dedicated to develop next-generation vaccines for the prevention of infectious diseases. We concentrate on a new class of vaccines, the messenger RNA or mRNA-based vaccines. More specifically, Ziphius focusses on self-amplifying mRNA-based vaccine. Since our founding in 2019, Ziphius has worked to develop...